120 Participants Needed

Spinal Cord Stimulation for Spinal Cord Injury

IS
KW
IS
Overseen ByIsmael Seanez, PHD
Age: Any Age
Sex: Any
Trial Phase: Academic
Sponsor: Washington University School of Medicine
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This study will help the investigators better understand the changes in short-term excitability and long-term plasticity of corticospinal, reticulospinal and spinal neural circuits and how the changes impact the improvements of spinal cord stimulation (SCS) mediated motor function.

Will I have to stop taking my current medications?

The trial requires that you do not use analgesics (pain relievers) within 24 hours before the study period. Other medications are not specifically mentioned, so it's best to discuss your current medications with the study team.

What data supports the effectiveness of the treatment Spinal Cord Stimulation for Spinal Cord Injury?

Research shows that combining transcutaneous spinal cord stimulation (a non-invasive method using electrodes to stimulate the spinal cord) with activity-based training can improve upper limb function in people with spinal cord injuries. Preliminary results from a clinical trial indicate that this combination leads to significant and sustained improvements in motor function, even in individuals with severe injuries.12345

Is transcutaneous spinal cord stimulation (tSCS) safe for humans?

Transcutaneous spinal cord stimulation (tSCS) is generally considered safe as it is a non-invasive method used in various studies for spinal cord injury rehabilitation, showing potential benefits without significant safety concerns reported.12678

How does the treatment of transcutaneous spinal cord stimulation differ from other treatments for spinal cord injury?

Transcutaneous spinal cord stimulation (tSCS) is unique because it is a non-invasive treatment that uses electrodes to stimulate the spinal cord, enhancing motor function and recovery in individuals with spinal cord injury. Unlike other therapies, tSCS can increase the excitability of spinal circuits and facilitate recovery by modulating the spinal cord's neural networks without surgery.123910

Research Team

IS

Ismael Seanez, PhD

Principal Investigator

Washington University School of Medicine

Eligibility Criteria

This trial is for individuals aged 16-65 with a traumatic spinal cord injury between C4-T9 levels, classified as ASIA C or D. They should have difficulty moving their legs independently and be at least one year post-injury. Healthy volunteers in the same age range without major health issues can also participate. Exclusions include severe comorbidities, implanted devices like pacemakers, drug use affecting the study, pregnancy, uncontrolled infections or illnesses that could interfere with exercises.

Inclusion Criteria

I am between 16 and 65 years old and do not have any major health issues.
I am 16-65 with a spinal injury at C4-T9, can follow commands, and have trouble moving my legs.

Exclusion Criteria

Healthy Volunteers younger than 16 or older than 65 years old, not providing consent or not able to consent, with any acute or chronic pain condition, with any acute or chronic disease of a major organ system, use of analgesics within 24 hours prior to the study period, use of caffeine within 3 hours of the study appointment
Participants with spinal cord injury (SCI) younger than 16 or older than 65 years old, not willing or able to provide consent, with any acute or chronic pain condition, with any acute or chronic disease of a major organ system, use of analgesics within 24 hours prior to the study appointment, use of caffeine within 3 hours of the study appointment, presence of tremors, spasms, and other significant involuntary movements, etiology of SCI other than trauma, concomitant neurologic disease traumatic brain injury (TBI) that will significantly impact the ability to follow through on study directions, multiple sclerosis (MS), stroke or peripheral neuropathy, history of significant medical illness (cardiovascular disease, uncontrolled diabetes, uncontrolled hypertension, osteoporosis, cancer, chronic obstructive pulmonary disease, severe asthma requiring hospitalization for treatment, renal insufficiency requiring dialysis, autonomic dysreflexia, etc.), severe joint contractures disabling or restricting lower limb movements, unhealed fracture, contracture, pressure sore, urinary tract infection or other uncontrolled infections, other illnesses that might interfere with lower extremity exercises or testing activities, depression, anxiety, or cognitive impairment, deficit of visuospatial orientation, sitting tolerance less than 1 hour, severe hearing or visual deficiency, miss more than 3 appointments without notification, unable to comply with any of the procedures in the protocol, botulinum toxin injection in lower extremity muscles in the prior six months, any passive implants (osteosynthesis material, metallic plates or screws) below T9, any implanted stimulator in the body (pacemaker, vagus nerve stimulator, etc.), history of alcoholism or another drug abuse, pregnancy (or possible pregnancy), having an Intrathecal Baclofen Therapy Pump (ITB pump), history of epilepsy

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Short-term Intervention

Participants receive 30 minutes of transcutaneous spinal cord stimulation and/or activity-based training to assess short-term neural excitability changes

30 minutes
1 visit (in-person)

Long-term Training

Participants undergo 4 weeks of activity-based training with transcutaneous spinal cord stimulation to assess long-term neural plasticity changes

4 weeks
Multiple visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • Activity-based training
  • Electrophysiology assessment - corticospinal tract
  • Electrophysiology assessment - reticulospinal tract
  • Electrophysiology assessment - spinal motoneuron
  • Transcutaneous spinal cord stimulation
Trial OverviewThe study examines how spinal cord stimulation (SCS) affects motor function recovery in people with spinal injuries by assessing changes in neural circuits' excitability and plasticity. It involves electrophysiology assessments of different neural tracts and activity-based training combined with transcutaneous SCS.
Participant Groups
6Treatment groups
Experimental Treatment
Group I: Experimental: Non-invasive spinal cord stimulation and strength trainingExperimental Treatment5 Interventions
This arm will receive transcutaneous spinal cord stimulation as participants perform strengthening exercises.
Group II: Experimental: Non-invasive spinal cord stimulation and precision trainingExperimental Treatment5 Interventions
This arm will receive transcutaneous spinal cord stimulation as participants perform precision-control and dexterity exercises.
Group III: Experimental: Non-invasive spinal cord stimulationExperimental Treatment4 Interventions
This arm will receive 30 minutes of transcutaneous spinal cord stimulation as participants rest.
Group IV: Experimental: Long-term activity-based training with non-invasive spinal cord stimulationExperimental Treatment5 Interventions
This arm will receive 4 weeks of activity-based training with transcutaneous spinal cord stimulation
Group V: Experimental: Activity-based training wtih non-invasive spinal cord stimulationExperimental Treatment5 Interventions
This arm will receive transcutaneous spinal cord stimulation as participants perform 30 minutes of activity-based training using leg movements.
Group VI: Experimental: Activity-based trainingExperimental Treatment4 Interventions
This arm will perform 30 minutes of activity-based training using leg movements.

Activity-based training is already approved in United States, European Union for the following indications:

🇺🇸
Approved in United States as Activity-Based Training for:
  • Spinal cord injury recovery
  • Traumatic brain injury rehabilitation
  • Neurological condition management
🇪🇺
Approved in European Union as Activity-Based Training for:
  • Spinal cord injury rehabilitation
  • Neurological condition management
  • Physical therapy for neurological disorders

Find a Clinic Near You

Who Is Running the Clinical Trial?

Washington University School of Medicine

Lead Sponsor

Trials
2,027
Recruited
2,353,000+

Findings from Research

Cervical transcutaneous spinal cord stimulation (tSCS) can effectively activate sensory fibers at lower stimulation intensities when the cathode electrode is positioned at the C7 or T1 vertebra, compared to C6, which may enhance rehabilitation outcomes for upper-limb motor recovery after spinal cord injury.
Using smaller electrode sizes not only lowers the activation threshold for sensory fibers but also optimizes the recruitment of these fibers before α-motor fibers, suggesting a strategic approach to improve hand muscle activation during tSCS therapy.
Optimizing sensory fiber activation during cervical transcutaneous spinal stimulation using different electrode configurations: A computational analysis.de Freitas, RM., Capogrosso, M., Nomura, T., et al.[2022]
Transcutaneous spinal cord stimulation (tSCS) shows potential for generating motor activity in individuals with spinal cord injury, but the overall quality of the studies reviewed was poor-to-fair, indicating a need for more rigorous research.
The review identified significant variability in stimulation parameters and outcome measurements across the 25 studies analyzed, highlighting the necessity for standardized methods to improve the reliability and comparability of tSCS research.
Transcutaneous spinal cord stimulation and motor responses in individuals with spinal cord injury: A methodological review.Taylor, C., McHugh, C., Mockler, D., et al.[2022]
A multicenter randomized clinical trial is investigating the effectiveness of combining spinal cord transcutaneous stimulation (scTS) with activity-based training (ABT) for improving upper extremity function in individuals with cervical spinal cord injury, showing promising preliminary results.
In a small sample of four participants, the combination of scTS and ABT led to immediate and sustained improvements in upper extremity function, with one participant experiencing a remarkable 5-fold increase in function, indicating potential for significant rehabilitation benefits.
Combining Spinal Cord Transcutaneous Stimulation with Activity-based Training to Improve Upper Extremity Function Following Cervical Spinal Cord Injury.Zhang, F., Carnahan, J., Ravi, M., et al.[2023]

References

Optimizing sensory fiber activation during cervical transcutaneous spinal stimulation using different electrode configurations: A computational analysis. [2022]
Transcutaneous spinal cord stimulation and motor responses in individuals with spinal cord injury: A methodological review. [2022]
Combining Spinal Cord Transcutaneous Stimulation with Activity-based Training to Improve Upper Extremity Function Following Cervical Spinal Cord Injury. [2023]
Change in neuroplasticity-related proteins in response to acute activity-based therapy in persons with spinal cord injury. [2018]
Activity-Based Restorative Therapies after Spinal Cord Injury: Inter-institutional conceptions and perceptions. [2020]
Spinal Cord Stimulation with Activity-Based Training: Effect on Spasticity. [2023]
Effects of transcutaneous spinal stimulation on spatiotemporal cortical activation patterns: a proof-of-concept EEG study. [2022]
Spinal direct current stimulation with locomotor training in chronic spinal cord injury. [2021]
Transcutaneous Spinal Cord Stimulation and Motor Rehabilitation in Spinal Cord Injury: A Systematic Review. [2021]
Neural Substrates of Transcutaneous Spinal Cord Stimulation: Neuromodulation across Multiple Segments of the Spinal Cord. [2022]